Ikaros negatively regulates inducible nitric oxide synthase expression in macrophages: Involvement of Ikaros phosphorylation by casein kinase 2
暂无分享,去创建一个
[1] J. Kuchar,et al. Recruitment of Ikaros to Pericentromeric Heterochromatin Is Regulated by Phosphorylation* , 2008, Journal of Biological Chemistry.
[2] Haemi Joo,et al. Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros. , 2007, Nutrition.
[3] P. Tripathi. Nitric oxide and immune response. , 2007, Indian journal of biochemistry & biophysics.
[4] S. Asa,et al. Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells. , 2006, Molecular endocrinology.
[5] Jing Wang,et al. Role of Histone Deacetylation in Cell-specific Expression of Endothelial Nitric-oxide Synthase* , 2005, Journal of Biological Chemistry.
[6] S. Asa,et al. The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibility. , 2005, Molecular endocrinology.
[7] D. Litchfield,et al. Order or chaos? An evaluation of the regulation of protein kinase CK2. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[8] A. Pautz,et al. Regulation of the expression of inducible nitric oxide synthase. , 2004, European journal of pharmacology.
[9] J. Houghton,et al. Influence of Casein Kinase II in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Human Rhabdomyosarcoma Cells , 2004, Clinical Cancer Research.
[10] E. Solary,et al. Casein Kinase II-mediated Phosphorylation of NF-κB p65 Subunit Enhances Inducible Nitric-oxide Synthase Gene Transcription in Vivo* , 2004, Journal of Biological Chemistry.
[11] K. Georgopoulos,et al. Phosphorylation Controls Ikaros's Ability To Negatively Regulate the G1-S Transition , 2004, Molecular and Cellular Biology.
[12] D. Litchfield,et al. Expression and regulation of protein kinase CK2 during the cell cycle , 2004, Molecular and Cellular Biochemistry.
[13] U. Förstermann,et al. Regulation of the Expression of Inducible Nitric Oxide Synthase , 2003, Biological chemistry.
[14] A. Rebollo,et al. Ikaros, Aiolos and Helios: Transcription regulators and lymphoid malignancies , 2003, Immunology and cell biology.
[15] L. Barsky,et al. Ikaros Isoform X Is Selectively Expressed in Myeloid Differentiation1 , 2003, The Journal of Immunology.
[16] C. Souchier,et al. Live-Cell Fluorescence Imaging Reveals the Dynamics of Protein Kinase CK2 Individual Subunits , 2003, Molecular and Cellular Biology.
[17] K. Georgopoulos,et al. A Molecular Dissection of the Repression Circuitry of Ikaros* , 2002, The Journal of Biological Chemistry.
[18] T. Kyo,et al. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia , 2002, Leukemia.
[19] D. Litchfield,et al. Interactions between Protein Kinase CK2 and Pin1 , 2002, The Journal of Biological Chemistry.
[20] K. Georgopoulos. Haematopoietic cell-fate decisions, chromatin regulation and ikaros , 2002, Nature Reviews Immunology.
[21] Christian Bogdan,et al. Nitric oxide and the immune response , 2001, Nature Immunology.
[22] H. Forman,et al. Redox signaling in macrophages. , 2001, Molecular aspects of medicine.
[23] K. Takenaka,et al. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. , 2000, Cancer research.
[24] K. Georgopoulos,et al. Ikaros Interactions with CtBP Reveal a Repression Mechanism That Is Independent of Histone Deacetylase Activity* , 2000, The Journal of Biological Chemistry.
[25] M. Seto,et al. Low frequency of expression of dominant-negative Ikaros isoforms in human leukemia and lymphoma cell lines. , 2000, Leukemia research.
[26] H. Sather,et al. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] S. Neben,et al. Defects in Hemopoietic Stem Cell Activity in Ikaros Mutant Mice , 1999, The Journal of experimental medicine.
[28] T. Kyo,et al. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. , 1999, Cancer research.
[29] H. Sather,et al. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[30] K. Georgopoulos,et al. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes , 1999, The EMBO journal.
[31] D. Litchfield,et al. Inducible Expression of Protein Kinase CK2 in Mammalian Cells , 1999, The Journal of Biological Chemistry.
[32] R. Kingston,et al. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. , 1999, Immunity.
[33] N. Heerema,et al. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[34] K. Georgopoulos,et al. Ikaros chromatin remodeling complexes in the control of differentiation of the hemo-lymphoid system. , 1999, Cold Spring Harbor symposia on quantitative biology.
[35] Jianjun Gao,et al. Autocrine/Paracrine IFN-αβ Mediates the Lipopolysaccharide-Induced Activation of Transcription Factor Stat1α in Mouse Macrophages: Pivotal Role of Stat1α in Induction of the Inducible Nitric Oxide Synthase Gene , 1998, The Journal of Immunology.
[36] I. Weissman,et al. Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Dower,et al. Activation of Nuclear Transcription Factor NF-κB by Interleukin-1 Is Accompanied by Casein Kinase II-mediated Phosphorylation of the p65 Subunit* , 1997, The Journal of Biological Chemistry.
[38] K. Georgopoulos,et al. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. , 1997, Immunity.
[39] K. Georgopoulos,et al. The role of the Ikaros gene in lymphocyte development and homeostasis. , 1997, Annual review of immunology.
[40] R. Bleackley,et al. In Vivo Regulation of Murine Granzyme B Gene Transcription in Activated Primary T Cells* , 1996, The Journal of Biological Chemistry.
[41] L. Johnson,et al. Active and Inactive Protein Kinases: Structural Basis for Regulation , 1996, Cell.
[42] K. Georgopoulos,et al. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins , 1994, Molecular and cellular biology.
[43] C. Turck,et al. The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. , 1994, Molecular and cellular biology.
[44] C. Nathan,et al. Role of interferon regulatory factor 1 in induction of nitric oxide synthase , 1994, The Journal of experimental medicine.
[45] C. Nathan,et al. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.
[46] Y. Vodovotz,et al. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta , 1993, The Journal of experimental medicine.
[47] S. Smale,et al. Both LyF-1 and an Ets protein interact with a critical promoter element in the murine terminal transferase gene , 1993, Molecular and cellular biology.
[48] D. Moore,et al. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. , 1992, Science.
[49] E. Krebs,et al. Phosphorylation of casein kinase II by p34cdc2 in vitro and at mitosis. , 1992, The Journal of biological chemistry.
[50] S. Smale,et al. LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes , 1991, Molecular and cellular biology.